{
  "zip": "30092",
  "sector": "Healthcare",
  "fullTimeEmployees": 5,
  "longBusinessSummary": "Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.",
  "city": "Norcross",
  "phone": "770 242 8723",
  "state": "GA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.guidedinc.com",
  "maxAge": 1,
  "address1": "5835 Peachtree Corners East",
  "fax": "770 242 8639",
  "industry": "Medical Devices",
  "address2": "Suite B",
  "previousClose": 0.401,
  "regularMarketOpen": 0.381,
  "twoHundredDayAverage": 0.3734,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.5,
  "navPrice": null,
  "averageDailyVolume10Day": 15480,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.401,
  "fiftyDayAverage": 0.3734,
  "trailingAnnualDividendRate": null,
  "open": 0.381,
  "averageVolume10days": 15480,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.829831,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.3601,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 19182,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 6548100,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 15480,
  "priceToSalesTrailing12Months": 70.409676,
  "dayLow": 0.3601,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 19182,
  "fiftyTwoWeekHigh": 0.5,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.31,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.5,
  "exchange": "PNK",
  "shortName": "GUIDED THERAPEUTICS INC",
  "longName": "Guided Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "GTHP",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_34654",
  "uuid": "5e39e48e-f84d-380f-beb5-ba206d8cb551",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 162.275,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -16.525,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 13096200,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -1.255,
  "sharesShort": 0,
  "sharesPercentSharesOut": 0,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.03818,
  "netIncomeToCommon": -1437000,
  "trailingEps": -0.173,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.53845,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": 1055203200,
  "floatShares": 6533820,
  "enterpriseValue": 15091572,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1553817600,
  "lastSplitFactor": "1:800",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1060646400,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": 0,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.381,
  "logo_url": "https://logo.clearbit.com/guidedinc.com"
}